Hepatoma Research
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Hepatoma Research
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig2

From:  Combined radiofrequency and chemoembolization vs. chemoembolization in management of hepatocellular carcinoma
Combined radiofrequency and chemoembolization <i>vs</i>. chemoembolization in management of hepatocellular carcinoma

Figure 2. Survival rates at 7 months and 1 year. Survival rate at 7 months was 100% in radiofrequency ablation (RFA) + trans-arterial chemoembolization (TACE) group and 96% in TACE group. One year survival rate was 88.8% in RFA + TACE group and 80% in TACE group with statistically significant difference. RFA: radiofrequency ablation; TACE: trans-arterial chemoembolization

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties